Premium
P4‐040: Use of recent research criteria for inclusion and use of biomarkers as endpoint in preclinical and prodromal Alzheimer's disease (AD) trials: An Alzheimer's disease neuroimaging initiative (ADNI) study
Author(s) -
Bertens Daniela,
Tijms Betty M.,
Scheltens Philip,
Visser Pieter Jelle
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.06.1744
Subject(s) - medicine , alzheimer's disease neuroimaging initiative , clinical trial , oncology , neuroimaging , asymptomatic , alzheimer's disease , disease , psychology , psychiatry